TP53 and neoplasm: Its ability to be down regulated by p53 ([42] and personal communication), well-known for its frequent inactivation in tumours, its in vitro transforming potential [43] and its ability to promote unscheduled entry into S-phase constitute essential features for the contribution of CDC25B to oncogenesis according to the proposed induced senescence model (for review [44]).